关节内注射重组人蛋白聚糖4减轻尤卡坦小型猪内侧半月板失稳后的软骨损伤
在29只尤卡坦小型猪单侧内侧半月板失稳模型中,术后1周起每周关节内注射3次重组人润滑素(rhPRG4)、rhPRG4+透明质酸或磷酸盐缓冲液,26周后评估软骨损伤。rhPRG4组内侧胫骨平台宏观软骨损伤显著低于磷酸盐缓冲液组(P=0.002),但三组微观损伤评分无差异(P=0.70)。作者认为关节内注射rhPRG4可能减缓创伤后骨关节炎的进展。
要点
- rhPRG4组内侧胫骨平台宏观软骨损伤显著低于磷酸盐缓冲液组(P=0.002)。
- rhPRG4+透明质酸组与磷酸盐缓冲液组宏观软骨损伤无差异(P=0.23)。
- 三组微观软骨损伤评分无差异(P=0.70)。
核心结论
- 所有组在DMM手术后均出现显著软骨退变,但接受rhPRG4治疗的动物软骨损伤最少且炎症较轻,提示关节内注射rhPRG4可能减缓创伤后骨关节炎的进展。
研究设计与样本
- 受控实验室研究,在29只尤卡坦小型猪中行单侧内侧半月板失稳(DMM)手术。
- 术后1周起每周关节内注射3次(每次3 mL):rhPRG4组(1.3 mg/mL,n=10)、rhPRG4+透明质酸组(1.3 mg/mL rhPRG4和3 mg/mL透明质酸[约950 kDA],n=10)、磷酸盐缓冲液组(n=9)。
- 术后26周取材,采用宏观(印度墨水)和微观(番红O-固绿和苏木精-伊红)评分系统评估软骨完整性,并通过酶联免疫吸附试验评估滑液PRG4水平、尿和血清CTX-II浓度以及滑液和血清IL-1β水平。
主要发现
- rhPRG4组内侧胫骨平台宏观软骨损伤显著少于磷酸盐缓冲液组(P=0.002)。
- rhPRG4+透明质酸组与磷酸盐缓冲液组宏观软骨损伤无差异(P=0.23)。
- 三组微观损伤评分无差异(P=0.70)。
- rhPRG4组滑液PRG4产量高于磷酸盐缓冲液组(P=0.033)。
- rhPRG4组尿CTX-II水平显著低于磷酸盐缓冲液组(P=0.013)和rhPRG4+透明质酸组(P=0.011),但血清CTX-II水平无此差异。
临床怎么用
- 作者认为,关节内注射rhPRG4可能减轻半月板损伤后的软骨损伤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lubricin, or proteoglycan 4 (PRG4), is a glycoprotein responsible for joint boundary lubrication. PRG4 has been shown previously to be down-regulated after traumatic joint injury such as a meniscal tear. Preliminary evidence suggests that intra-articular injection of PRG4 after injury will reduce cartilage damage in rat models of surgically induced posttraumatic osteoarthritis. OBJECTIVE: To determine the efficacy of intra-articular injection of full-length recombinant human lubricin (rhPRG4) for reducing cartilage damage after medial meniscal destabilization (DMM) in a preclinical large animal model. STUDY DESIGN: Controlled laboratory study. METHODS: Unilateral DMM was performed in 29 Yucatan minipigs. One week after DMM, animals received 3 weekly intra-articular injections (3 mL per injection): (1) rhPRG4 (1.3 mg/mL; n = 10); (2) rhPRG4+hyaluronan (1.3 mg/mL rhPRG4 and 3 mg/mL hyaluronan [~950 kDA]; n = 10); and (3) phosphate-buffered saline (PBS; n = 9). Hindlimbs were harvested 26 weeks after surgery. Cartilage integrity was evaluated by use of macroscopic (India ink) and microscopic (safranin O-fast green and hematoxylin and eosin) scoring systems. Secondary outcomes evaluated via enzyme-linked immunosorbent assay (ELISA) included PRG4 levels in synovial fluid, carboxy-terminal telepeptide of type II collagen (CTX-II) concentrations in urine and serum, and interleukin 1β (IL-1β) levels in synovial fluid and serum. RESULTS: The rhPRG4 group had significantly less macroscopic cartilage damage in the medial tibial plateau compared with the PBS group ( P = .002). No difference was found between the rhPRG4+hyaluronan and PBS groups ( P = .23). However, no differences in microscopic damage scores were observed between the 3 groups ( P = .70). PRG4 production was elevated in the rhPRG4 group synovial fluid compared with the PBS group ( P = .033). The rhPRG4 group presented significantly lower urinary CTX-II levels, but not serum levels, when compared with the PBS ( P = .013) and rhPRG4+hyaluronan ( P = .011) groups. In serum and synovial fluid, both rhPRG4 ( P = .006; P = .017) and rhPRG4+hyaluronan groups ( P = .009; P = .03) presented decreased IL-1β levels. CONCLUSION: All groups exhibited significant cartilage degeneration after DMM surgery. However, animals treated with rhPRG4 had the least amount of cartilage damage and less inflammation, providing evidence that intra-articular injections of rhPRG4 may slow the progression of posttraumatic osteoarthritis. CLINICAL RELEVANCE: Patients with meniscal trauma are at high risk for posttraumatic osteoarthritis. This study demonstrates that an intra-articular injection regimen of rhPRG4 may attenuate cartilage damage after meniscal injury.
引用
- Waller KA, Chin KE, Jay GD, et al. Intra-articular Recombinant Human Proteoglycan 4 Mitigates Cartilage Damage After Destabilization of the Medial Meniscus in the Yucatan Minipig. Am J Sports Med. 2017. PMID: 28129516. doi:10.1177/0363546516686965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。